Skip to main content
SpringerLink
Log in
Book cover

Basal Cell Carcinoma pp 1–18Cite as

Epidemiology and Risk Factors of Basal Cell Carcinoma

  • Chapter
  • First Online:

  • 1244 Accesses

Abstract

Basal cell carcinoma (BCC) is the most common cancer worldwide among the Caucasian population. The majority of BCCs are diagnosed in Europe, the United States, and Australia. In the United States, accurate estimates of the burden of BCC are difficult to measure due to the exclusion of BCC from national cancer registries. In the 2012 US commercial insurance population, 822,593 persons were found to have a new BCC. Among the 2012 Medicare population, 726,840 persons were found to have BCC. Asgari et al. estimated the annual incidence of BCC in the United States to be approximately 2 million with an increasing rate of 0.87% per year.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–80.

    Article  CAS  PubMed  Google Scholar 

  2. Goldenberg G, Karagiannis T, Palmer JB, et al. Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: a retrospective cohort study. J Am Acad Dermatol. 2016;75:957–66 e2.

    Article  PubMed  Google Scholar 

  3. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151:1081–6.

    Article  PubMed  Google Scholar 

  4. Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998–2012. JAMA Dermatol. 2015;151:976–81.

    Article  PubMed  Google Scholar 

  5. Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol. 2017;177:359–72.

    Article  CAS  PubMed  Google Scholar 

  6. Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978–2012: empirical relationships. JAMA Dermatol. 2014;150:1063–71.

    Article  PubMed  Google Scholar 

  7. de Vries E, Micallef R, Brewster DH, et al. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol. 2012;148:347–54.

    Article  PubMed  Google Scholar 

  8. Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjaer SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: rapid incidence increase among young Danish women. Int J Cancer. 2010;127:2190–8.

    Article  CAS  PubMed  Google Scholar 

  9. Jurciukonyte R, Vincerzevskiene I, Krilaviciute A, et al. Epidemiology of basal cell carcinoma in Lithuania, 1996–2010. Br J Dermatol. 2013;169:1100–5.

    Article  CAS  PubMed  Google Scholar 

  10. Reinau D, Surber C, Jick SS, Meier CR. Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities. Br J Cancer. 2014;111:203–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Carsin AE, Sharp L, Comber H. Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland. Br J Dermatol. 2011;164:822–9.

    Article  CAS  PubMed  Google Scholar 

  12. Flohil SC, Seubring I, van Rossum MM, et al. Trends in basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol. 2013;133:913–8.

    Article  CAS  PubMed  Google Scholar 

  13. Rudolph C, Schnoor M, Eisemann N, et al. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. 2015;13:788–97.

    PubMed  Google Scholar 

  14. Lipozenčić J, Celić D, Strnad M, et al. Skin cancers in Croatia, 2003–2005: epidemiological study. Coll Antropol. 2010;34:865–9.

    PubMed  Google Scholar 

  15. Videnović G, Miljus D, Ilic D, et al. Nonmelanoma skin cancer in the population of the city of Belgrade in the period 1999–2011. Srp Arh Celok Lek. 2015;143:290–5.

    Article  PubMed  Google Scholar 

  16. Bielsa I, Soria X, Esteve M, et al. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. Br J Dermatol. 2009;161:1341–6.

    Article  CAS  PubMed  Google Scholar 

  17. Jung GW, Metelitsa AI, Dover DC, et al. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988–2007. Br J Dermatol. 2010;163:146–54.

    CAS  PubMed  Google Scholar 

  18. Demers AA, Nugent Z, Mihalcioiu C, et al. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005;53:320–8.

    Article  PubMed  Google Scholar 

  19. Karagas MR, Greenberg ER, Spencer SK, et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer. 1999;81:555–9.

    Article  CAS  PubMed  Google Scholar 

  20. Wu S, Han J, Li WQ, et al. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol. 2013;178:890–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Asgari MM, Moffet HH, Ray GT, et al. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998–2012. JAMA Dermatol. 2015;151:976–81.

    Article  PubMed  Google Scholar 

  22. Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977–1978 and 1998–1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev. 2003;12:1105–8.

    PubMed  Google Scholar 

  23. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. J Am Acad Dermatol. 2001;45:528–36.

    Article  CAS  PubMed  Google Scholar 

  24. Rawashdeh MA, Matalka I. Basal cell carcinoma of the maxillofacial region: site distribution and incidence rates in Arab/Jordanians, 1991 to 2000. J Oral Maxillofac Surg. 2004;62:145–9.

    Article  PubMed  Google Scholar 

  25. Sella T, Goren I, Shalev V, et al. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006–11. Br J Dermatol. 2015;172:202–7.

    Article  CAS  PubMed  Google Scholar 

  26. Sng J, Koh D, Siong WC, et al. Skin cancer trends among Asians living in Singapore from 1968 to 2006. J Am Acad Dermatol. 2009;61:426–32.

    Article  PubMed  Google Scholar 

  27. Munyao TM, Othieno-Abinya NA. Cutaneous basal cell carcinoma in Kenya. East Afr Med J. 1999;76:97–100.

    CAS  PubMed  Google Scholar 

  28. Norval M, Kellett P, Wright CY. The incidence and body site of skin cancers in the population groups of South Africa. Photodermatol Photoimmunol Photomed. 2014;30:262–5.

    Article  PubMed  Google Scholar 

  29. Custódio G, Locks LH, Coan MF, et al. Epidemiology of basal cell carcinomas in Tubarao, Santa Catarina (SC), Brazil between 1999 and 2008. An Bras Dermatol. 2010;85:819–26.

    Article  PubMed  Google Scholar 

  30. Abarca JF, Casiccia CC. Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987–2000. Photodermatol Photoimmunol Photomed. 2002;18:294–302.

    Article  PubMed  Google Scholar 

  31. Foster HM, Webb SJ. Skin cancer in the North Solomons. Aust N Z J Surg. 1988;58:397–401.

    Article  CAS  PubMed  Google Scholar 

  32. Staples MP, Elwood M, Burton RC, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10.

    Article  PubMed  Google Scholar 

  33. Richmond-Sinclair NM, Pandeya N, Ware RS, et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol. 2009;129:323–8.

    Article  CAS  PubMed  Google Scholar 

  34. Brougham ND, Dennett ER, Tan ST. Changing incidence of non-melanoma skin cancer in New Zealand. ANZ J Surg. 2011;81:633–6.

    Article  PubMed  Google Scholar 

  35. Wu S, Han J, Li WQ, Li T, Qureshi AA. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol. 2013;178:890–7.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lubeek SF, van Vugt LJ, Aben KK, van de Kerkhof PC, Gerritsen MP. The epidemiology and clinicopathological features of basal cell carcinoma in patients 80 years and older: a systematic review. JAMA Dermatol. 2017;153:71–8.

    Article  PubMed  Google Scholar 

  37. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294:681–90.

    Article  CAS  PubMed  Google Scholar 

  38. Evans SS, Jih MH, Goldberg LH, Kimyai-Asadi A. Increased burden of melanoma and nonmelanoma skin cancer in young women. Dermatol Surg. 2014;40:1385–9.

    Article  CAS  PubMed  Google Scholar 

  39. Muzic JG, Schmitt AR, Wright AC, et al. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc. 2017;92:890–8.

    Article  PubMed  Google Scholar 

  40. Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol. 2012;67:552–62.

    Article  PubMed  Google Scholar 

  41. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147:41–7.

    Article  CAS  PubMed  Google Scholar 

  42. McCusker M, Basset-Seguin N, Dummer R, et al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer. 2014;50:774–83.

    Article  PubMed  Google Scholar 

  43. Flohil SC, van der Leest RJ, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer. 2013;49:2365–75.

    Article  PubMed  Google Scholar 

  44. Wehner MR, Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Chren MM. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. JAMA Dermatol. 2015;151:382–8.

    Article  PubMed  Google Scholar 

  45. Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomark Prev. 2010;19:1686–95.

    Article  Google Scholar 

  46. Barton V, Armeson K, Hampras S, et al. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res. 2017;309:243–51.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Wehner MR, Serrano WC, Nosrati A, et al. All cause mortality in patients with basal and squamous cell carcinoma: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;78(4):663–72.

    Article  PubMed  Google Scholar 

  48. Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev. 2015;24:141–9.

    Article  PubMed  Google Scholar 

  49. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48:425–9.

    Article  PubMed  Google Scholar 

  50. Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002–2006 and 2007–2011. Am J Prev Med. 2015;48:183–7.

    Article  PubMed  Google Scholar 

  51. Migden M, Xie J, Wei J, Tang W, Herrera V, Palmer JB. Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014. J Am Acad Dermatol. 2017;77:55–62 e3.

    Article  PubMed  Google Scholar 

  52. Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. PharmacoEconomics. 2011;29:863–74.

    Article  PubMed  Google Scholar 

  53. Wu X, Elkin EE, Marghoob AA. Burden of basal cell carcinoma in USA. Future Oncol. 2015;11:2967–74.

    Article  CAS  PubMed  Google Scholar 

  54. Stern RS, Weinstein MC, Baker SG. Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol. 1986;122:537–45.

    Article  CAS  PubMed  Google Scholar 

  55. Moyer VA, Force USPST. Behavioral counseling to prevent skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:59–65.

    Article  PubMed  Google Scholar 

  56. Sanchez G, Nova J, Rodriguez-Hernandez AE, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database Syst Rev. 2016;7:CD011161.

    PubMed  Google Scholar 

  57. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354:723–9.

    Article  CAS  PubMed  Google Scholar 

  58. Bath-Hextall F, Leonardi-Bee J, Somchand N, Webster A, Delitt J, Perkins W. Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst Rev. 2007;1:CD005414.

    Google Scholar 

  59. Weinstock MA, Bingham SF, Digiovanna JJ, et al. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. J Invest Dermatol. 2012;132:1583–90.

    Article  CAS  PubMed  Google Scholar 

  60. Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med. 1990;323:789–95.

    Article  CAS  PubMed  Google Scholar 

  61. Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician’s health study. Arch Dermatol. 2000;136:179–84.

    Article  CAS  PubMed  Google Scholar 

  62. Tangrea JA, Edwards BK, Taylor PR, et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst. 1992;84:328–32.

    Article  CAS  PubMed  Google Scholar 

  63. Levine N, Moon TE, Cartmel B, et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomark Prev. 1997;6:957–61.

    CAS  Google Scholar 

  64. Clouser MC, Roe DJ, Foote JA, Harris RB, Alberts DS. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence. Nutr Cancer. 2010;62:1058–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Duffield-Lillico AJ, Slate EH, Reid ME, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst. 2003;95:1477–81.

    Article  CAS  PubMed  Google Scholar 

  66. Muranushi C, Olsen CM, Green AC, Pandeya N. Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis. J Am Acad Dermatol. 2016;74:108–19 e1.

    Article  CAS  PubMed  Google Scholar 

  67. Ali FR, Craythorne EE, Al-Niaimi F. Chemoprevention of basal cell carcinoma. Br J Dermatol. 2016;175:1404.

    Article  CAS  PubMed  Google Scholar 

  68. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373:1618–26.

    Article  CAS  PubMed  Google Scholar 

  69. Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for skin cancer in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316:436–47.

    Article  PubMed  Google Scholar 

  70. Hoorens I, Vossaert K, Ongenae K, Brochez L. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening. Br J Dermatol. 2016;174:1258–65.

    Article  CAS  PubMed  Google Scholar 

  71. NCCN Clinical Practice Guidelines in Oncology. Basal Cell Skin Cancer. Version 1.2018. 2017. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf. Accessed 1 Jan 2018.

  72. American Cancer Society. Basal and Squamous Cell Skin Cancer. 2018. https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer.html. Accessed 1 Jan 2018.

  73. Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case–case–control study. Br J Cancer. 2006;94:743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B Biol. 2001;63:8–18.

    Article  CAS  Google Scholar 

  75. Trakatelli M, Morton C, Nagore E, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24:312–29.

    PubMed  Google Scholar 

  76. Rubin AI, Chen EH, Ratner D. Basal-Cell Carcinoma. N Engl J Med. 2005;353:2262–9.

    Article  CAS  PubMed  Google Scholar 

  77. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer: I. basal cell carcinoma. Arch Dermatol. 1995;131:157–63.

    Article  CAS  PubMed  Google Scholar 

  78. Vitasa BC, Taylor HR, Strickland PT, et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer. 1990;65:2811–7.

    Article  CAS  PubMed  Google Scholar 

  79. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst. 2002;94:224–6.

    Article  PubMed  Google Scholar 

  80. Ferrucci LM, Vogel RI, Cartmel B, Lazovich D, Mayne ST. Indoor tanning in businesses and homes and risk of melanoma and nonmelanoma skin cancer in 2 US case-control studies. J Am Acad Dermatol. 2014;71:882–7.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Wehner MR, Shive ML, Chren M-M, Han J, Qureshi AA, Linos E. Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ. 2012;345:e5909.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Zhang M, Qureshi AA, Geller AC, Frazier L, Hunter DJ, Han J. Use of tanning beds and incidence of skin cancer. J Clin Oncol. 2012;30:1588–93.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Karagas MR, Zens MS, Li Z, et al. Early-onset basal cell carcinoma and indoor tanning: a population-based study. Pediatrics. 2014;134:e4.

    Article  PubMed  PubMed Central  Google Scholar 

  84. NTP (National Toxicology Program). Report on carcinogens. 9th Ed. Research Triangle Park: U.S. Department of Health and Human Services, Public Health Service; 2000. https://ntp.niehs.nih.gov/pubhealth/roc/previous_editions/.

  85. NTP (National Toxicology Program). Report on carcinogens. 14th Ed. Research Triangle Park: U.S. Department of Health and Human Services, Public Health Service; 2016. http://ntp.niehs.nih.gov/go/roc14/.

  86. Boyles S. WHO: tanning beds cause cancer. WebMD 2018. https://www.webmd.com/beauty/news/20090728/who-tanning-beds-cause-cancer. Accessed 3 Jan 2018.

  87. Dangers of indoor tanning | American Academy of Dermatology. 2018. https://www.aad.org/media/stats/prevention-and-care. Accessed 3 Jan 2018.

  88. Australia Bans Tanning Salons. Medscape 2018. http://www.medscape.com/viewarticle/838407. Accessed 3 Jan 2018.

  89. Stern RS. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66:553–62.

    Article  CAS  PubMed  Google Scholar 

  90. Lim JL, Stern RS. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Investig Dermatol. 2005;124:505–13.

    Article  CAS  PubMed  Google Scholar 

  91. Hearn RMR, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol. 2008;159:931–5.

    Article  CAS  PubMed  Google Scholar 

  92. Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol. 2005;152:755–7.

    Article  CAS  PubMed  Google Scholar 

  93. Black RJ, Gavin AT. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol. 2006;154:566–7.

    Article  CAS  PubMed  Google Scholar 

  94. Weischer M, Blum A, Eberhard F, Röcken M, Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol. 2004;84:370–4.

    Article  PubMed  Google Scholar 

  95. Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case–control study. J Investig Dermatol. 2013;133:1950–5.

    Article  CAS  PubMed  Google Scholar 

  96. Ruiter R, Visser LE, Eijgelsheim M, et al. High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study. Eur J Cancer. 2010;46:2467–72.

    Article  CAS  PubMed  Google Scholar 

  97. McDonald E, Freedman DM, Alexander BH, et al. Prescription diuretic use and risk of basal cell carcinoma in the Nationwide U.S. radiologic technologists cohort. Cancer Epidemiol Biomarkers Prev. 2014;23:1539.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Jensen AØ, Thomsen HF, Engebjerg MC, Olesen AB, Sørensen HT, Karagas MR. Use of photosensitising diuretics and risk of skin cancer: a population-based case–control study. Br J Cancer. 2008;99:1522.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Kaae J, Boyd HA, Hansen AV, Wulf HC, Wohlfahrt J, Melbye M. Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:2942.

    Article  CAS  PubMed  Google Scholar 

  100. Karagas MR, Nelson HH, Zens MS, et al. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology. 2007;18:776–84.

    Article  PubMed  Google Scholar 

  101. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD. Radiation-induced skin carcinomas of the head and neck. Radiat Res. 1991;125:318–25.

    Article  CAS  PubMed  Google Scholar 

  102. Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. Skin cancer after X-Ray treatment for scalp ringworm. Radiat Res. 2002;157:410–8.

    Article  CAS  PubMed  Google Scholar 

  103. Levi F, Moeckli R, Randimbison L, Te V-C, Maspoli M, La Vecchia C. Skin cancer in survivors of childhood and adolescent cancer. Eur J Cancer. 2006;42:656–9.

    Article  PubMed  Google Scholar 

  104. Schwartz JL, Kopecky KJ, Mathes RW, Leisenring WM, Friedman DL, Deeg HJ. Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Radiat Res. 2009;171:155–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Watt TC, Inskip PD, Stratton K, et al. Radiation-related risk of basal cell carcinoma: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2012;104:1240–50.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Yoshinaga S, Hauptmann M, Sigurdson AJ, et al. Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists. Int J Cancer. 2005;115:828–34.

    Article  CAS  PubMed  Google Scholar 

  107. Ron E, Preston DL, Mabuchi K, et al. Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes Control. 1998;9:393–401.

    Article  CAS  PubMed  Google Scholar 

  108. Naruke Y, Nakashima M, Suzuki K, et al. Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation. Cancer. 2009;115:3782–90.

    Article  CAS  PubMed  Google Scholar 

  109. Sugiyama H, Misumi M, Kishikawa M, et al. Skin cancer incidence among atomic bomb survivors from 1958 to 1996. Radiat Res. 2014;181:531–9.

    Article  CAS  PubMed  Google Scholar 

  110. Maloney ME. Arsenic in dermatology. Dermatol Surg. 1996;22:301–4.

    CAS  PubMed  Google Scholar 

  111. Karagas MR, Stukel TA, Morris JS, et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol. 2001;153:559–65.

    Article  CAS  PubMed  Google Scholar 

  112. Boonchai W, Green A, Ng J, Dicker A, Chenevix-Trench G. Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication. J Am Acad Dermatol. 2000;43:664–9.

    Article  CAS  PubMed  Google Scholar 

  113. Humans IWGotEoCRt. Arsenic, metals, fibres, and dusts. IARC Monogr Eval Carcinog Risks Hum. 2012;100:11–465.

    Google Scholar 

  114. Leonardi G, Vahter M, Clemens F, et al. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case–control study. Environ Health Perspect. 2012;120:721–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681–91.

    Article  PubMed  Google Scholar 

  116. Hartevelt MM, Bavinck JNB, Kootte AMM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49(3):506–9.

    Article  CAS  PubMed  Google Scholar 

  117. Moloney FJ, Comber H, O’Lorcain P, O’Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol. 2006;154:498–504.

    Article  CAS  PubMed  Google Scholar 

  118. Omland S, Gniadecki R, Hædersdal M, Helweg-Larsen J, Omland L. Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study. JAMA Dermatol. 2016;152:177–83.

    Article  PubMed  Google Scholar 

  119. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet. 1998;351:623–8.

    Article  CAS  PubMed  Google Scholar 

  120. Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol. 2001;137:459–63.

    CAS  PubMed  Google Scholar 

  121. Leisenring W, Friedman DL, Flowers MED, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006;24:1119–26.

    Article  PubMed  Google Scholar 

  122. DePry JL, Vyas R, Lazarus HM, Caimi PF, Gerstenblith MR, Bordeaux JS. Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol. 2015;151:775–82.

    Article  PubMed  Google Scholar 

  123. Sørensen HT, Mellemkjær L, Nielsen GL, Baron JA, Olsen JH, Karagas MR. Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst. 2004;96:709–11.

    Article  PubMed  Google Scholar 

  124. Chakravarty EF, Michaud K, Wolfe F. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol. 2005;32:2130.

    CAS  PubMed  Google Scholar 

  125. Baibergenova AT, Weinstock MA, Group VT. Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial. J Eur Acad Dermatol Venereol. 2012;26:1109–15.

    Article  CAS  PubMed  Google Scholar 

  126. Silverberg MJ, Leyden W, Warton EM, Quesenberry JCP, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013;105:350–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–32.

    Article  PubMed  Google Scholar 

  128. Honglei Z, Guobin S, Songting W. The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis. Int J STD AIDS. 2015;27:568–75.

    Google Scholar 

  129. Crum-Cianflone N, Hullsiek K, Satter E, et al. Cutaneous malignancies among hiv-infected persons. Arch Intern Med. 2009;169:1130–8.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Reference GH. MC1R gene. Genetics home reference 2018. https://ghr.nlm.nih.gov/gene/MC1R. Accessed 15 Jan 2018.

  131. Box NF, Chen W, Sturm RA, et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Investig Dermatol. 2001;116:224–9.

    Article  CAS  PubMed  Google Scholar 

  132. Bastiaens MT, Huurne JAC, Kielich C, et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet. 2001;68:884–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Han J, Kraft P, Colditz GA, Wong J, Hunter DJ. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer. 2006;119:1976–84.

    Article  CAS  PubMed  Google Scholar 

  134. Gudbjartsson DF, Sulem P, Stacey SN, et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet. 2008;40:886.

    Article  CAS  PubMed  Google Scholar 

  135. Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327:794.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Berlin NL, Cartmel B, Leffell DJ, Bale AE, Mayne ST, Ferrucci LM. Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype. Cancer Epidemiol. 2015;39:1078–83.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Stacey SN, Gudbjartsson DF, Sulem P, et al. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat Genet. 2008;40:1313.

    Article  CAS  PubMed  Google Scholar 

  138. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41:221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Stacey SN, Sulem P, Masson G, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet. 2009;41:909.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Stacey SN, Sulem P, Jonasdottir A, et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet. 2011;43:1098.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. GWAS Catalog. 2018. http://www.ebi.ac.uk/gwas/. Accessed 15 Jan 2018.

  142. Castori M, Morrone A, Kanitakis J, Grammatico P. Genetic skin diseases predisposing to basal cell carcinoma. Eur J Dermatol. 2012;22:299–309.

    PubMed  Google Scholar 

  143. Hahn H, Wicking C, Zaphiropoulos PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996;85:841–51.

    Article  CAS  PubMed  Google Scholar 

  144. Evans DG, Farndon PA. Nevoid basal cell carcinoma syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle, WA: University of Washington, Seattle; 2015.

    Google Scholar 

  145. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8:743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  146. Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48:168–76.

    Article  PubMed  Google Scholar 

  147. Daya-Grosjean L. Xeroderma pigmentosum and skin cancer. Adv Exp Med Biol. 2008;637:19–27.

    Article  CAS  PubMed  Google Scholar 

  148. Goeteyn M, Geerts M, Kint A, De Weert J. The bazex-dupré-christol syndrome. Arch Dermatol. 1994;130:337–42.

    Article  CAS  PubMed  Google Scholar 

  149. Michaëlsson G, Olsson E, Westermark P. The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis. Acta Derm Venereol. 1981;61:497–503.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Georgia Dermatology Partners, Atlanta, GA, USA

    Waqas R. Shaikh

  2. The University of Texas MD Anderson Cancer Center, Department of Dermatology, Houston, TX, USA

    Waqas R. Shaikh & Zeena Y. Nawas

Authors
  1. Waqas R. Shaikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeena Y. Nawas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zeena Y. Nawas .

Editor information

Editors and Affiliations

  1. The University of Texas MD Anderson Cancer Center, Departments of Dermatology and Head and Neck Surgery, Mohs Surgery Center, Houston, TX, USA

    Michael R. Migden

  2. The University of Texas MD Anderson Cancer Center, Department of Dermatology, Houston, TX, USA

    Leon Chen

  3. University of Texas McGovern Medical School at Houston, Department of Dermatology, Houston, TX, USA

    Sirunya Silapunt

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shaikh, W.R., Nawas, Z.Y. (2020). Epidemiology and Risk Factors of Basal Cell Carcinoma. In: Migden, M., Chen, L., Silapunt, S. (eds) Basal Cell Carcinoma. Springer, Cham. https://doi.org/10.1007/978-3-030-26887-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26887-9_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26886-2

  • Online ISBN: 978-3-030-26887-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation